Skip to main content

Want a detailed portfolio tracker?

Bright Minds Biosciences (DRUG) P/E (2021 - 2026)

Bright Minds Biosciences (DRUG) P/E from Mar 22, 2021 to Jul 21, 2026. The TTM Bright Minds Biosciences (DRUG) P/E is -31.41. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Bright Minds Biosciences (DRUG)

YearP/EChange
2026-31.41-15.27%
2025-37.07-82.18%
2024-208.07+21339.91%
2023-0.97+24.01%
2022-0.78-76.57%
2021-3.34N/A

Comparison Bright Minds Biosciences (DRUG) P/E with competitors

Bright Minds Biosciences (DRUG) P/E is -31.41.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.24%
FGENFibroGen Inc0.24-100.76%
CHRSCoherus Biosciences Inc0.85-102.70%
FBIOFortress Biotech Inc0.95-103.02%
ORMPOramed Pharmaceuticals Inc1.50-104.79%
AGENAgenus Inc3.01-109.58%
INVAInnoviva Inc3.15-110.04%
VXRTVaxart Inc3.55-111.30%
CRMDCorMedix Inc3.63-111.55%
CVACCureVac N.V.4.45-114.15%
GLPGGalapagos NV4.86-115.47%
SRPTSarepta Therapeutics Inc4.88-115.54%
ABEOAbeona Therapeutics Inc5.39-117.15%
ABUSArbutus Biopharma Corp5.60-117.82%
ZVRAZevra Therapeutics Inc5.89-118.74%
SPROSpero Therapeutics Inc6.23-119.83%
CGENCompugen Ltd6.31-120.10%
RIGLRigel Pharmaceuticals6.87-121.88%
SLXNSilexion Therapeutics Corp7.30-123.23%
OMEROmeros Corporation9.26-129.48%
AUPHAurinia Pharmaceuticals Inc9.58-130.52%
PLXProtalix BioTherapeutics Inc10.89-134.68%
ACADAcadia Pharmaceuticals Inc11.73-137.34%
TBPHTheravance Biopharma Inc12.26-139.04%
ADMAAdma Biologics Inc12.42-139.54%
HRMYHarmony Biosciences Holdings Inc13.82-144.00%
SABSSAB Biotherapeutics Inc14.14-145.01%
NAGENiagen Bioscience Inc14.82-147.18%
INCYIncyte Corp15.82-150.38%
REGNRegeneron Pharmaceuticals Inc15.86-150.49%
PBYIPuma Biotechnology Inc17.32-155.13%
CPRXCatalyst Pharmaceuticals Inc17.44-155.52%
EXELExelixis Inc17.54-155.84%
TGTXTG Therapeutics Inc18.97-160.39%
MDXGMimedx Group Inc20.55-165.44%
XOMAXOMA Royalty Corp22.87-172.83%
ARGXArgen X SE24.30-177.36%
CTMXCytomX Therapeutics Inc24.82-179.03%
XOMAOXOMA Royalty Corp25.34-180.70%
HALOHalozyme Therapeutics Inc25.62-181.58%
XOMAPXOMA Royalty Corp25.67-181.73%
VRTXVertex Pharmaceuticals Inc27.99-189.13%
RPRXRoyalty Pharma plc - Class A28.69-191.34%
SLNOSoleno Therapeutics Inc29.02-192.38%
ASNDAscendis Pharma A/S30.09-195.79%
LGNDLigand Pharmaceuticals Inc - Class B37.91-220.71%
APLSApellis Pharmaceuticals Inc39.02-224.24%
BMRNBiomarin Pharmaceutical Inc42.21-234.40%
KRYSKrystal Biotech Inc45.34-244.37%
ONCBeiGene Ltd69.54-321.41%
PHARPharming Group N.V.75.03-338.88%
TECHBio-Techne Corp101.96-424.63%
VCELVericel Corp109.92-449.98%
ALNYAlnylam Pharmaceuticals Inc117.96-475.59%
GMABGenmab140.29-546.68%
TLXTelix Pharmaceuticals Ltd162.15-616.29%
CORTCorcept Therapeutics Inc212.86-777.73%